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Structures of many of the cell surface receptor-ligand
complexes mediating the interactions between T cells
and target cells have been determined in the past ten
years. While snapshots of T cell receptors bound to
their peptide-MHC ligands appear to have defined a
general interaction or “docking” solution, many of the
most fundamental structural questions in antigen re-
cognition lack detailed answers and thus pose excit-
ing experimental challenges for the future.
Introduction
The mechanism by which the adaptive immune system
discriminates self versus non-self is dependent on the
appropriate recognition of antigens presented to T cells
by major histocompatibility complex (MHC) proteins
(Figure 1). Cells ingest foreign proteins (antigens), di-
gest them into small peptides, and load them onto MHC
proteins. After trafficking of the peptide-MHC (pMHC)
complex to the cell membrane, the composite surface
comprised of peptide and MHC is surveyed by αβ T
lymphocytes through their T cell receptors (TCR) (Fig-
ure 1B). The TCR is a genetically recombined receptor,
analogous to an antibody, that is composed of two
chains, either α and β in αβ T cells or γ and δ in γδ T
cells. The binding site of the TCR is comprised of six
loops called complementarity determining regions
(CDRs), with each chain contributing three loops, called
CDR1, 2, and 3 (Figure 1B). The CDR1 and 2 loop se-
quences are constant for each type of chain and are
therefore referred to as “germline derived,” whereas the
CDR3 loops vary in an almost unlimited fashion and
largely dictate the TCR specificity for peptide. When
the TCR interrogates the peptide cargo carried by MHC
(Figure 1B), the T cell is either stimulated to perform its
effector functions (cytokine release or cytotoxicity) or
moves on to the next pMHC surface presented to it.
How αβ T cells interact with peptide-MHC has been
a particularly attractive field for structural biologists
(Figure 1). However, a realistic examination reveals that
two fundamental questions structural biologists ex-
pected to answer remain almost complete mysteries:
(1) what are the structural rules for αβ TCR recognition
of antigenic peptides in the context of MHC molecules?
and (2) how can a limited set of TCR patrol a much
larger universe of peptides presented by MHC mole-
cules? Here we focus on where structural studies of
TCR/pMHC complexes have taken us with respect to
these two questions. There are numerous comprehen-*Correspondence: kcgarcia@stanford.edusive reviews to which we direct the reader (Hennecke
and Wiley, 2001; Housset and Malissen, 2003; Rudolph
et al., 2002).
The Inherent Reactivity of the TCR for Peptide-MHC
The interface between an αβ TCR and pMHC repre-
sents the structural solution to almost 400 million years
of coevolution. While we can describe this solution
in great structural detail gleaned from structures of
approximately twelve unique TCR/pMHC complexes
(Housset and Malissen, 2003; Rudolph et al., 2002), the
underlying “rules of engagement” for αβ TCR recogni-
tion of pMHC are no clearer than they were ten years
ago. How is the αβ TCR innately programmed to recog-
nize virtually any MHC molecule? Some general prin-
ciples have emerged from the current database of com-
plexes (Figures 1B and 2). Briefly, in all of the complex
structures, the TCR has a particular orientation on the
pMHC surface (Figure 2A) that places the germline-
encoded CDR1 and CDR2 loops in contact with the
conserved helical residues of the MHC while the highly
variable, somatically recombined CDR3 loops primarily
interact with the peptide.
That the initial αβ TCR/pMHC structures had similar
docking solutions was consistent with the Jerne hy-
pothesis that TCR and MHC genes evolved an inherent
predisposition to interact with one another (Jerne,
1971). Antibodies, in contrast, do not coevolve with
their highly diverse antigens (proteins, peptides, small
molecules, etc.) and thus have little restriction in their
ligand binding modes. Similarly, γδ TCR are not depen-
dent on MHC presentation of antigen; it is clear the
binding mode diverges sharply from that of an αβ TCR
(Figure 2G) (Adams et al., 2005). The extension of the
Jerne hypothesis is that the αβ TCR innate preference,
or “bias,” for recognition of MHC is dictated by sets of
conserved TCR/MHC contacts. Therefore, we expected
that subsequent TCR/pMHC complexes would reveal
common sets of amino acid contacts between the
germline-encoded (i.e., invariant) residues of the CDR1
and 2 loops and the MHC helices that would serve
as “rules” for TCR/pMHC interactions. The implica-
tions being that we could eventually construct a con-
tact table of conserved interactions between each TCR
and MHC.
The reality is that when the present group of TCR/
pMHC complexes are aligned on the MHC, there is a
variation or “wobble” in the diagonal binding orienta-
tion of about ± 45° between TCR (Figures 2B–2F) (Ru-
dolph et al., 2002). This variation results in different sets
of amino acid contacts between the various TCR/MHC
interfaces, while the overall orientation of the TCR’s Vα
and Vβ domains on the MHC remain in approximately
the same regions. Even in cases where different αβ TCR
share the same β chain and interact with the same
MHC, the β contacts on the MHC helices differ (Figure
2B) (Housset and Malissen, 2003). This variation poses
a question: what constrains the docking topology if
there are not obviously shared TCR/MHC contacts?
The basic dilemma is whether the globally similar di-
agonal orientations of the TCR on the MHC are a prod-
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334Figure 1. Low- and High-Resolution Views of T Cell Recognition
(A) Model of extracellular complex architectures within a T cell/antigen presenting cell interface based on known structural information of the
respective receptor ligand complexes. Trimolecular complexes of TCR/MHC/CD8 and TCR/MHC/CD4 have been modeled based on superpo-
sition of the MHC in each of the respective TCR/pMHC and MHC/CD8 and MHC/CD4 binary complexes. The transmembrane segments of
the CD3 and CD3 subunits have been drawn in with the charges indicated necessary for assembly with the TCR chains.
(B) A TCR/pMHC complex (left) and a closeup of the interface (right) showing the “germline” CDR1 and 2 TCR loops contacting the MHC
helices, while the centrally located and genetically recombined CDR3 contact the antigenic peptide bound to the MHC.uct of (1) “external forces,” such as steric constraints o
iimposed by other molecules (coreceptors) which sur-
round the TCR during signaling (CD3, CD8, CD4, etc.) p
cand which influence T cell development or (2) “internal
forces,” such as conserved interatomic contacts in the m
Tinterface between TCR and MHC that have been re-
fined through millions of years of coevolution. Put sim- l
ply, is the diagonal docking mode a kiss between pas-
sionate lovers (internal forces), or is it a loveless kiss a
cborne of an arranged marriage (external forces)?
Compelling arguments can be made for the “internal a
Cforces” argument based on functional data demon-
strating an inherent TCR reactivity with MHC (Blackman o
set al., 1986; Zerrahn et al., 1997). TCR αβ chain pairs of
unknown specificity—which have not undergone T cell t
vmaturation in the thymus and therefore have not been
“educated” to recognize MHC—still possess an affinity T
hfor MHC. T cells also seem to require a weak stimula-
tory signal for their prolonged survival that is delivered p
rby interactions with self-MHC. The most compelling
structural argument for a primordial set of TCR/MHC t
lrecognition determinants was revealed in a class II
TCR/pMHC complex containing a particular β chain n
C(Figure 2D) (Maynard et al., 2005). In this complex, the
β chain CDR1 and CDR2 loops form an identical set of l
Tinteratomic contacts to the MHC helix as seen in an-
other TCR sharing the same β chain complexed with l
Ra related MHC allele (Figure 2D) but different peptide
(Reinherz et al., 1999). Almost all of the residues con- f
Ttacted by the β chains of the TCR are shared across allther alleles of this particular MHC molecule. The strik-
ng coincidence of the interactions in these two com-
lexes strongly implies that these are conserved an-
hor points between this β chain (Vβ8.2) and MHC
olecule (I-A). In other words, the correspondence of
CR/MHC contacts could be a glimpse of one of the
ong sought-after “codons” of MHC restriction.
On the other hand, in support of the external forces
rgument, we must remember that the TCR alone is not
ompetent for signaling but exists within a higher-order
ssembly containing the CD3 signaling subunits and
D4 or CD8 coreceptors (Figure 1). The intermolecular
rganization of the entire signaling complex may place
patial restrictions on MHC binding that prevent any-
hing but the canonical orientation (Figure 1). The in-
ariant coreceptors may serve to couple, or bridge, the
CR with the MHC in a locked orientation in which they
ave little choice about their docking orientation. Com-
arison of TCR/pMHC complex structures which do not
equire the assistance of coreceptor for signaling with
hose that do shows some interesting differences (Bus-
epp et al., 2003), but both types fall within the range of
ormal docking topologies. Structures of the CD4 and
D8 coreceptors bound to MHC indicate that it is un-
ikely there is simultaneous coreceptor contact with the
CR in an individual TCR/pMHC/CD4 or CD8 trimolecu-
ar complex that would serve as bridge (Figure 1).
ather, it is more likely that the TCR has orientational
reedom in pMHC recognition and that the diagonal
CR/MHC binding mode is the result of constellations
Minireview
335Figure 2. TCR Footprint over Peptide-MHC
Global convergence of the TCR/pMHC footprint in spite of large
variations in the interatomic contacts between the TCR germline
components (CDR1 and 2) and the MHC helices is shown. The
MHC have been aligned on the β sheet platforms so that the varia-
tion in the TCR CDR loop overlays is apparent.of conserved interfacial contacts that are exceedingly
complex and blurred by hundreds of million years of
coevolution. Remember each TCR αβ heterodimer can
recognize different MHC surfaces that lack a single
shared residue, yet each may possess a common
structural determinant of “MHC-ness.”
The few energetic studies of TCR/pMHC interactions
have produced conflicting results. Alanine scanning of
a murine TCR with MHC class I indicated a fairly broad
energetic landscape distributed across all CDR loops
(Manning et al., 1998). A recent study refined this obser-
vation by showing that residues on the MHC helices
seem to guide the initial MHC recognition by the TCR,
while the peptide mainly influenced how long the TCR
would stay bound (Wu et al., 2002). Put simply, the con-
served MHC helical residues provide the “bias” to re-
cruit the TCR regardless of the identity of the antigenic
peptide in order to enable the TCR CDR3 to “scan” the
peptide contents of every MHC (Wu et al., 2002).
In apparent contradiction to this study is a recent ala-
nine scan of an unusual human TCR that is almost ex-
clusively used in T cell responses to Epstein-Barr virus(Figure 2C) (Borg et al., 2005). This work showed that
the interaction between the CDR1 and CDR2 loops
and the MHC helices were worth very little energetically
in the contact interface, with almost all of the binding
energetics focused on the peptide-CDR3 contacts. A
recent human TCR complexed with an MHC class II
molecule demonstrated dramatically the notion that
CDR1 and 2 are energetically dispensable for MHC re-
cognition (Hahn et al., 2005). This complex has the
most unconventional docking orientation seen so far:
CDR1 and 2 make few contacts of any kind with MHC,
while the CDR3s have extensive contact with the pep-
tide as well as the α helices (Figure 2E). Importantly,
however, despite their seemingly antithetical results,
neither study breaks the basic paradigm set forth in the
initial structures: the canonical binding orientations of
the α and β chains over the MHC are maintained.
CDR3 Plasticity and Crossreactivity
Several complexes have shown large-scale rearrange-
ments of TCR CDR3 loops upon peptide binding (Garcia
et al., 1998), and companion thermodynamic studies indi-
cate entropic penalties are incurred during this process
(Housset and Malissen, 2003; Rudolph et al., 2002). The
functional importance of this conformational adapta-
bility has been attributed to the need for the TCR to
recognize a universe of structurally diverse peptide
antigens much larger in number than its own combina-
torial diversity.
Is this really true? Recent data suggest that TCR are
much less degenerate, both structurally and function-
ally, than assumed. There is only one structure of a
single TCR bound to two different pMHC complexes
where the peptides have substantially different se-
quences (Reiser et al., 2003). A comparison of these
complexes shows that there are not large-scale confor-
mational changes of either the α or β CDR3. Rather
there are en bloc movements of similar CDR3β loop
conformations that form nearly identical interactions
with position 6 of the peptide in both complexes (Reiser
et al., 2003). Similarly, human and mouse complexes
with different agonist and antagonist peptide-MHC
show almost no CDR3 deformation. Functional studies
are increasingly calling into question the assumption of
a broadly promiscuous TCR enabled by CDR3 mallea-
bility (Maynard et al., 2005). Given the exquisite func-
tional specificity observed in most TCR systems, the
reality may be that CDR3 can assume different confor-
mations to recognize a limited number of alternative
peptides with a high degree of specificity, but they are
not easily accommodating limp noodles. At this point,
it is unclear to what extent crossreactivity is indeed an
innate property of T cell recognition, and if so, whether
it is achieved by CDR3 plasticity and/or repositioning
of the TCR/MHC docking orientation.
Future Perspectives
How do we identify if rules of engagement for MHC
exist? If the CDR1 and CDR2 loop contacts with the
MHC helices carried no predetermined recognition
code, shouldn’t we sometimes see the binding orienta-
tion of the α and β chains reversed? Does the TCR rep-
ertoire, prior to thymic selection against self-reactive
TCR (negative selection), contain pairs of αβ hetero-
dimers that recognize the MHC in alternative orien-
tations? A significant proportion (w30%) of the pre-
Cell
336thymic (i.e., pre-development) TCR repertoire can be f
iaccounted for by MHC reactivity (Blackman et al., 1986;
Zerrahn et al., 1997); however, we do not know what p
cstructural form this reactivity takes. Given that 99.9%
of T cells are deleted during maturation in the thymus, a
Cperhaps the diagonal orientation is only one of may dif-
ferent recognition solutions that occur when α and β t
tchains are randomly paired. Marrack, Kappler, and col-
leagues suggest that the origins of MHC bias will most n
nclearly reveal themselves in the repertoire of TCR prior
to development (Huseby et al., 2005). In this recent ele- t
tgant study, relaxation of the stringency by which the
thymus deletes self-reactive TCR resulted in TCR that
tare much more crossreactive with different pMHC than
normal—that is a “pan MHC” bias was more pro- r
snounced. The role of negative thymic selection, then,
may be to focus the TCR away from their MHC helical v
greactivity and more toward peptide specificity. This
could explain why we are not seeing the structural etiol- t
oogy of TCR/MHC bias in the “matured” TCR which have
been the targets of structural studies: these determi-
Anants have been filtered out.
Currently, there is not yet a sufficient database of
Tcomplex structures for detailed rules of TCR/pMHC in-
t
teractions to obviously emerge. This gives some jus- t
tification for the continued structure determinations d
of many TCR/pMHC complexes, although technically H
these complexes remain a major feat. We cannot possi-
bly crystallize enough different complexes to delineate
Sall of the possible contacts motifs between different α
and β chains and different MHC molecules. Given the
Asmall slice of the T cell repertoire we could ever hope
2
to access structurally, proof-of-concept will arise from
B
structural analysis of a focused set of TCR against a E
given pMHC, in tandem with genetically tractable
B
mouse models. Within one system, how many struc- C
tural solutions are there for the interactions between a S
given α or β chain and a specific pMHC? Dual-reactive B
(class I and class II) TCR are known, and their struc- (
tures complexed with both MHC classes might give us G
Ta hint whether a given α and β chain pair sniffs out a
shared MHC structural determinant. Complexes of TCR H
(with self and foreign ligands that are substantially dif-
Hferent structurally are important to understand the
structural origins of TCR “crossreactivity” (i.e., alloreac- H
tivity). Ultimately, perhaps there will be sets of αβ TCR H
Mdocking geometries on MHC that will fall into a limited
Jnumber of groups, depending on the context of the
CDR3-peptide interactions. Such complexity is daunt- M
Jing to sort out structurally, but the initial question—are
Ithere rules?—can be tackled in a focused manner.
MAn Important Caveat
SGiven the difficulty, so far, in seeing a recognition code
nfrom the crystal structures, we must be mindful of a
Rpossible complication to this approach. What we see
R
in crystalline TCR/pMHC complexes may not represent 1
the true structural origins of TCR/MHC reactivity. There R
is abundant biophysical evidence of CDR3 loop plastic- n
ity and induced fit upon binding (Housset and Malissen, a
2003; Rudolph et al., 2002). Such a dynamic model por- R
tends the possibility that there may be a transition state p
in the initial TCR/MHC binding process that relaxes into W
(a set of CDR1 and 2 contacts which are dependent on
the CDR3 interaction with peptide—which will be dif- Zerent for each CDR3 sequence (Wu et al., 2002). If such
s the case, then the most energetically stable com-
lexes we see in crystals may not represent the “en-
ounter” complex where the bias might be manifested,
nd there may be as many TCR/pMHC orientations as
DR3 sequences. The fact that TCR/pMHC interac-
ions are highly dynamic in nature suggests that solu-
ion-phase spectroscopic techniques like nuclear mag-
etic resonance and single-molecule flourescence will
eed to be increasingly incorporated into our structural
oolbox. The technical challenges here are great, given
he size and complexity of TCR and pMHC molecules.
We hope we have conveyed the fantastic progress
hat has been made through structural studies of T cell
ecognition. However, the collective experimental re-
ults have raised more questions than they have pro-
ided definitive answers. For the structural immunolo-
ist, these are exciting times, as we are now realizing
hat, far from the story being over, we are just at the tip
f the iceberg.
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